期刊文献+

Angiogenesis in gastrointestinal stromal tumors:From bench to bedside 被引量:2

下载PDF
导出
摘要 Gastrointestinal stromal tumors(GISTs)are rare neoplasms with an estimated incidence from 0.78 to 1-1.5 patients per 100000.They most commonly occur in the elderly during the eighth decade of life affecting predominantly the stomach,but also the small intestine,the omentum,mesentery and rectosigmoid.The available treatments for GIST are associated with a significant rate of recurrent disease and adverse events.Thorough understanding of GIST’s pathophysiology and translation of this knowledge into novel regimens or drug repurposing is essential to counter this challenge.The present review summarizes the existing evidence about the role of angiogenesis in GIST’s development and progression and discusses its clinical underpinnings.
出处 《World Journal of Gastrointestinal Oncology》 SCIE 2022年第8期1469-1477,共9页 世界胃肠肿瘤学杂志(英文版)(电子版)
  • 相关文献

参考文献1

二级参考文献44

  • 1Miettinen M, Lasota J. Histopathology of gastrointestinal stromaltumor. J Surg Oncol 2011; 104: 865-873 [PMID: 22069171 DOI:10.1002/jso.21945].
  • 2Rubin BP. Gastrointestinal stromal tumours: an update.Histopathology 2006; 48: 83-96 [PMID: 16359540].
  • 3Boichuk S, Parry JA, Makielski KR, Litovchick L, Baron JL,Zewe JP, Wozniak A, Mehalek KR, Korzeniewski N, SeneviratneDS, Sch-ffski P, Debiec-Rychter M, DeCaprio JA, Duensing A.The DREAM complex mediates GIST cell quiescence and is anovel therapeutic target to enhance imatinib-induced apoptosis.Cancer Res 2013; 73: 5120-5129 [PMID: 23786773 DOI:10.1158/0008-5472.CAN-13-0579].
  • 4Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, LongleyBJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B,Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors:A consensus approach. Hum Pathol 2002; 33: 459-465 [PMID:12094370].
  • 5Miettinen M, Lasota J. Gastrointestinal stromal tumors: reviewon morphology, molecular pathology, prognosis, and differentialdiagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478 [PMID:17090188].
  • 6Joensuu H. Predicting recurrence-free survival after surgery forGIST. Lancet Oncol 2009; 10: 1025 [PMID: 19793677 DOI:10.1016/S1470-2045(09)70267-0].
  • 7Huang H, Liu YX, Zhan ZL, Liang H, Wang P, Ren XB. Differentsites and prognoses of gastrointestinal stromal tumors of thestomach: report of 187 cases. World J Surg 2010; 34: 1523-1533[PMID: 20145924 DOI: 10.1007/s00268-010-0463-y].
  • 8Goh BK, Chow PK, Yap WM, Kesavan SM, Song IC, PaulPG, Ooi BS, Chung YF, Wong WK. Which is the optimal riskstratification system for surgically treated localized primaryGIST- Comparison of three contemporary prognostic criteria in171 tumors and a proposal for a modified Armed Forces Instituteof Pathology risk criteria. Ann Surg Oncol 2008; 15: 2153-2163[PMID: 18546045 DOI: 10.1245/s10434-008-9969-z].
  • 9Wong NA. Gastrointestinal stromal tumours-an update forhistopathologists. Histopathology 2011; 59: 807-821 [PMID:21668468 DOI: 10.1111/j.1365-2559.2011.03812.x].
  • 10Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathologyand prognosis at different sites. Semin Diagn Pathol 2006; 23:70-83 [PMID: 17193820].

共引文献15

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部